These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 34699141)
1. Review of Poultry Recombinant Vector Vaccines. Hein R; Koopman R; García M; Armour N; Dunn JR; Barbosa T; Martinez A Avian Dis; 2021 Sep; 65(3):438-452. PubMed ID: 34699141 [TBL] [Abstract][Full Text] [Related]
2. Current and future vaccines and vaccination strategies against infectious laryngotracheitis (ILT) respiratory disease of poultry. García M Vet Microbiol; 2017 Jul; 206():157-162. PubMed ID: 28057380 [TBL] [Abstract][Full Text] [Related]
3. Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek's disease, infectious bursal disease, Newcastle disease, and fowl pox. Sharma JM; Zhang Y; Jensen D; Rautenschlein S; Yeh HY Avian Dis; 2002; 46(3):613-22. PubMed ID: 12243525 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Protective Efficacy When Combining Turkey Herpesvirus-Vector Vaccines. Dunn JR; Dimitrov KM; Miller PJ; Garcia M; Turner-Alston K; Brown A; Hartman A Avian Dis; 2019 Mar; 63(1):75-83. PubMed ID: 31251522 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Protection Efficacy of a Serotype 1 Marek's Disease Virus-Vectored Bivalent Vaccine Against Infectious Laryngotracheitis and Marek's Disease. Gimeno IM; Cortes AL; Faiz NM; Hernandez-Ortiz BA; Guy JS; Hunt HD; Silva RF Avian Dis; 2015 Jun; 59(2):255-62. PubMed ID: 26473676 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of a turkey herpesvirus double construct vaccine (HVT-ND-IBD) against challenge with different strains of Newcastle disease, infectious bursal disease and Marek's disease viruses. van Hulten MCW; Cruz-Coy J; Gergen L; Pouwels H; Ten Dam GB; Verstegen I; de Groof A; Morsey M; Tarpey I Avian Pathol; 2021 Feb; 50(1):18-30. PubMed ID: 33063529 [TBL] [Abstract][Full Text] [Related]
7. Current status of virus-vectored vaccines against pathogens that affect poultry. Romanutti C; Keller L; Zanetti FA Vaccine; 2020 Oct; 38(45):6990-7001. PubMed ID: 32951939 [TBL] [Abstract][Full Text] [Related]
8. Combination of Two Marek's Disease Virus Vectors Shows Effective Vaccination Against Marek's Disease, Infectious Bursal Disease, and Newcastle Disease. Ishihara Y; Esaki M; Saitoh S; Yasuda A Avian Dis; 2016 Jun; 60(2):473-9. PubMed ID: 27309290 [TBL] [Abstract][Full Text] [Related]
10. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein. Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus. Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832 [TBL] [Abstract][Full Text] [Related]
12. Long-term protection against a virulent field isolate of infectious laryngotracheitis virus induced by inactivated, recombinant, and modified live virus vaccines in commercial layers. Palomino-Tapia VA; Zavala G; Cheng S; García M Avian Pathol; 2019 Jun; 48(3):209-220. PubMed ID: 30640536 [TBL] [Abstract][Full Text] [Related]
13. Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens. Vagnozzi A; Zavala G; Riblet SM; Mundt A; García M Avian Pathol; 2012; 41(1):21-31. PubMed ID: 22845318 [TBL] [Abstract][Full Text] [Related]
14. Pros and Cons on Use of Live Viral Vaccines in Commercial Chicken Flocks. Ganapathy K; Parthiban S Avian Dis; 2024 Jan; 67(4):410-420. PubMed ID: 38300660 [TBL] [Abstract][Full Text] [Related]
15. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens. Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090 [TBL] [Abstract][Full Text] [Related]
16. Immunity Elicited by a Turkey Herpesvirus-Vectored Newcastle Disease Vaccine in Turkey Against Challenge With a Recent Genotype IV Newcastle Disease Virus Field Strain. El Khantour A; Darkaoui S; Tatár-Kis T; Mató T; Essalah-Bennani A; Cazaban C; Palya V Avian Dis; 2017 Sep; 61(3):378-386. PubMed ID: 28957008 [TBL] [Abstract][Full Text] [Related]
18. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens. Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943 [TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of a novel recombinant Marek's disease virus vector vaccine against infectious bursal disease in chickens with or without maternal antibodies. Li K; Liu Y; Zhang Y; Gao L; Liu C; Cui H; Qi X; Gao Y; Zhong L; Wang X Vet Immunol Immunopathol; 2017 Apr; 186():55-59. PubMed ID: 28413051 [TBL] [Abstract][Full Text] [Related]
20. The safe and effective use of fowlpox virus as a vector for poultry vaccines. McMillen JK; Cochran MD; Junker DE; Reddy DN; Valencia DM Dev Biol Stand; 1994; 82():137-45. PubMed ID: 7958468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]